Blueprint Medicines Corp

Ownership Transactions Reported by 23 Insiders

Symbol
BPMC on Nasdaq
Location
45 Sidney Street, Cambridge, MA

Insiders trading volume in the past year

Blueprint Medicines Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Jeffrey W. Albers Director $9.33M -$5.7M -37.9% Jul 17, 2025
Nicholas Lydon Director $6.17M Jun 12, 2024
Christopher K. Murray Chief Technical Operations $3.45M Mar 7, 2024
Kate Haviland Chief Executive Officer, Director $2.54M -$2.04M -44.5% Jul 17, 2025
Philina Lee Chief Commercial Officer $2.1M -$331K -13.6% Jul 17, 2025
Christina Rossi Chief Operating Officer $952K -$2.3M -70.8% Jul 17, 2025
Fouad Namouni President, R & D $952K -$576K -37.7% Jul 17, 2025
George Demetri Director $837K Jun 21, 2022
Debra Durso-Bumpus Chief People Officer $793K -$458K -36.6% Jul 17, 2025
Percy H. Carter Chief Scientific Officer $793K -$788K -49.8% Jul 17, 2025
Michael Landsittel Chief Financial Officer $793K -$469K -37.2% Jul 17, 2025
Tracey L. McCain EVP & Chief Legal Officer $793K -$467K -37.1% Jul 17, 2025
Ariel Hurley Principal Accounting Officer $670K -$1.09M -62% Jul 17, 2025
Charles A. Rowland Jr Director $591K Jun 2, 2021
Tango Therapeutics, Inc. Director $411K Dec 8, 2021
L. Becker Hewes Chief Medical Officer $289K -$891K -75.5% Jul 17, 2025
Lonnel Coats Director $47.9K -$1.87M -97.5% Jul 17, 2025
Habib J. Dable Director $0 Jul 17, 2025
Mark Alan Goldberg Director $0 Jul 17, 2025
Daniella Beckman Director $0 Jul 17, 2025
Alexis Borisy Director $0 Jul 17, 2025
John Tsai Director $0 Jul 17, 2025
Lynn Seely Director $0 Jul 17, 2025

Recent Insider Transactions by Companies or Individuals for Blueprint Medicines Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.